The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBabcock Regulatory News (BAB)

Share Price Information for Babcock (BAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 521.50
Bid: 522.50
Ask: 524.00
Change: 4.00 (0.77%)
Spread: 1.50 (0.287%)
Open: 516.50
High: 526.50
Low: 509.00
Prev. Close: 517.50
BAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restatement of pass-through revenue for HY22

3 Nov 2022 12:13

RNS Number : 2482F
Babcock International Group PLC
03 November 2022
 

 

This replaces RNS No 2379F. Change to the RNS Headline only, which now reads: Restatement of pass-through revenue for HY22. There is no change to the content of the announcement.

 

 

Restatement of pass-through revenue and backlog for the half year ended 30 September 2021

 

3 November 2022

 

As outlined on 28 July 2022, Babcock International Group PLC's ("Babcock" or "the Group") full year results for the 2022 financial year (FY22) included a restatement of FY21 revenue and contract backlog. This was as a consequence of a re-examination of the presentation of pass-through revenue, as described on page three of the FY22 results statement.

 

Babcock has today published the restated revenue and associated backlog for the six months ended 30 September 2021 (HY22), ahead of its forthcoming half year results for six months ended 30 September 2022 (HY23).

 

As a result, in the Land sector revenue and cost of revenue decreases by £96.9 million and contract backlog decreases by £511.6 million in HY22.

 

There are no other impacts to the HY22 financial information.

 

The HY23 results will be held on the 22 November 2022.

 

A presentation of these restatements has been made available on our website at:

www.babcockinternational.com/investors/results-and-presentations

 

ENDS

 

For further information:

Andrew Gollan, Director of Investor Relations +44 (0)7936 039004

Kate Hill, Group Director of Communications +44 (0)20 7355 5312

 

Tulchan Communications

Olivia Peters / Harry Cameron +44 (0)20 7353 4200  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFSUFEDEESESF
Date   Source Headline
20th Sep 20177:00 amRNSTrading Update
8th Sep 201710:41 amRNSPublication of a Prospectus
17th Aug 201711:37 amRNSHolding(s) in Company
16th Aug 201711:54 amRNSDirector/PDMR Shareholding
13th Jul 20173:48 pmRNSResult of AGM
13th Jul 20177:00 amRNSAnnual General Meeting Trading Update
29th Jun 20177:00 amRNSContract Award
27th Jun 201712:32 pmRNSDirector/PDMR Shareholding
22nd Jun 201712:00 pmRNSDirector/PDMR Shareholding
20th Jun 201711:53 amRNSDirector/PDMR Shareholding
19th Jun 201710:53 amRNSDirector/PDMR Shareholding
15th Jun 20173:58 pmRNSDirector/PDMR Shareholding
13th Jun 20175:08 pmRNSNotice of AGM
7th Jun 20175:24 pmRNSHolding(s) in Company
7th Jun 20174:55 pmRNSDirector/PDMR Shareholding
7th Jun 20171:17 pmRNSDirector/PDMR Shareholding
1st Jun 201710:11 amRNSPublication of Final Terms
30th May 20175:23 pmRNSDirector/PDMR Shareholding
24th May 20173:43 pmRNSHolding(s) in Company
24th May 20177:00 amRNSFinal Results
19th May 20179:34 amRNSHolding(s) in Company
2nd May 20179:59 amRNSHolding(s) in Company
13th Apr 201710:09 amRNSHolding(s) in Company
13th Apr 20178:55 amRNSHolding(s) in Company
11th Apr 20179:26 amRNSHolding(s) in Company
3rd Apr 20177:00 amRNSPreferred bidder for Royal Navy support contract
29th Mar 20174:38 pmRNSHolding(s) in Company
27th Mar 20173:01 pmRNSDirector/PDMR Shareholding
27th Mar 20172:58 pmRNSDirector/PDMR Shareholding
27th Mar 201712:10 pmRNSDirector/PDMR Shareholding
27th Mar 20177:22 amRNSMagnox decommissioning contract
24th Mar 20179:54 amRNSHolding(s) in Company
14th Mar 20177:00 amRNSRealignment Presentation
28th Feb 20177:00 amRNSTrading Update
24th Feb 20171:00 pmRNSHolding(s) in Company
15th Feb 201712:11 pmRNSHolding(s) in Company
9th Feb 20174:53 pmRNSHolding(s) in Company
7th Feb 20175:00 pmRNSDirector Declaration
3rd Feb 20175:23 pmRNSHolding(s) in Company
20th Jan 201710:01 amRNSDirector/PDMR Shareholding
5th Jan 20179:00 amRNSFOMEDEC Contract Award
12th Dec 20161:19 pmRNSDirector Declaration
28th Nov 20164:18 pmRNSHolding(s) in Company
28th Nov 201611:07 amRNSDirector/PDMR Shareholding
23rd Nov 20163:48 pmRNSHolding(s) in Company
23rd Nov 20162:56 pmRNSHolding(s) in Company
22nd Nov 20167:00 amRNSHalf-year Report
21st Nov 201611:13 amRNSContract Award
21st Oct 20164:11 pmRNSHolding(s) in Company
17th Oct 20167:00 amRNSCapital Markets Day site visit

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.